Q32 Bio Statistics
Total Valuation
Q32 Bio has a market cap or net worth of $40.85 million. The enterprise value is $8.84 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Q32 Bio has 12.30 million shares outstanding. The number of shares has increased by 92.00% in one year.
| Current Share Class | 12.30M |
| Shares Outstanding | 12.30M |
| Shares Change (YoY) | +92.00% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 15.72% |
| Float | 5.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.57
| Current Ratio | 4.57 |
| Quick Ratio | 4.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -33.50% |
| Return on Invested Capital (ROIC) | -139.52% |
| Return on Capital Employed (ROCE) | -93.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$979,023 |
| Employee Count | 43 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Q32 Bio has paid $21,000 in taxes.
| Income Tax | 21,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.42% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -86.42% |
| 50-Day Moving Average | 2.67 |
| 200-Day Moving Average | 2.07 |
| Relative Strength Index (RSI) | 60.77 |
| Average Volume (20 Days) | 8,915,650 |
Short Selling Information
The latest short interest is 277,802, so 2.26% of the outstanding shares have been sold short.
| Short Interest | 277,802 |
| Short Previous Month | 272,900 |
| Short % of Shares Out | 2.26% |
| Short % of Float | 5.06% |
| Short Ratio (days to cover) | 1.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | -26.39M |
| Operating Income | -43.50M |
| Pretax Income | -42.08M |
| Net Income | -42.10M |
| EBITDA | -43.08M |
| EBIT | -43.50M |
| Earnings Per Share (EPS) | -$3.45 |
Full Income StatementBalance Sheet
The company has $49.04 million in cash and $17.03 million in debt, giving a net cash position of $32.01 million or $2.60 per share.
| Cash & Cash Equivalents | 49.04M |
| Total Debt | 17.03M |
| Net Cash | 32.01M |
| Net Cash Per Share | $2.60 |
| Equity (Book Value) | -18.45M |
| Book Value Per Share | -1.50 |
| Working Capital | 39.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$38.79 million and capital expenditures -$2,000, giving a free cash flow of -$38.79 million.
| Operating Cash Flow | -38.79M |
| Capital Expenditures | -2,000 |
| Free Cash Flow | -38.79M |
| FCF Per Share | -$3.15 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |